PROVIDER PROFILE · NPI 1720076151

Thomas Mehlhoff

Orthopedic SurgeryHouston, TXI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

1,344

Unique beneficiaries

—

Total services

1,808

Distinct HCPCS

Medicare payment

$137K

Peer benchmark

Total Medicare services vs. 1,568 Orthopedic Surgery providers in TX — above median (cohort median 1,443).

PRESCRIBING · PART D · 2024

Total Rx claims

792

Beneficiaries

—

Total drug cost

$3K

Distinct drugs

Brand share

16.4%

Top prescribed drugs

Meloxicam222 claims

Cephalexin210 claims

Tramadol Hcl124 claims

Tramadol Hcl/Acetaminophen47 claims

Methylprednisolone46 claims

QUALITY · MIPS · 2024

Final MIPS score

100.0

Quality

0.0

Cost

0.0

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

1.05%

Individual

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Thomas Mehlhoff's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
ORTHOPEDIC HOSPITAL LTD	112	356
Christopher Eriksen Certified Registered Nurse Anesthetist (CRNA) · Houston, TX	67	172
Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Houston, TX	25	61
Jeffrey London Diagnostic Radiology · Houston, TX	19	66
NPI 1366441750	16	60
UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER	12	29

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history